课题基金 / 基金详情

SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER

SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER
雄激素独立型前列腺癌的序贯激素治疗
批准号：
6279943
负责人：
GLENN J BUBLEY
金额：
$2.49万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279943
关键词：
aminoglutethimide clinical research combination chemotherapy cortisol drug screening /evaluation hormone therapy human subject human therapy evaluation neoplasm /cancer chemotherapy prostate neoplasms

项目摘要

项目成果

GLENN J BUBLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this single center pilot study is to determine the effectiveness of sequential hormonal therapy wth aminoglutethemide and hydrocortisone in patients with androgen-independent prostate cancer currently treated with bicalutamide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER
海外基金